EXEL
Exelixis Inc
Price:  
41.95 
USD
Volume:  
2,103,843.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EXEL Relative Valuation

9.0%
Upside

As of 2026-03-31, the Relative Valuation of Exelixis Inc (EXEL) is 45.71 USD. This relative valuation is based on P/E multiples. With the latest stock price at 41.95 USD, the upside of Exelixis Inc based on Relative Valuation is 9.0%.

The range of the Relative Valuation is 27.48 - 72.08 USD.

Range Selected
Trailing P/E multiples 9.1x - 19.1x 11.6x
Forward P/E multiples 12.0x - 24.3x 19.1x
Fair Price 27.48 - 72.08 45.71
Upside -34.5% - 71.8% 9.0%
41.95 USD
Stock Price
45.71 USD
Fair Price

EXEL Relative Valuation - Historical P/E Data

Date P/E
2026-03-30 13.92
2026-03-27 13.78
2026-03-26 14.06
2026-03-25 14.20
2026-03-24 13.80
2026-03-23 13.74
2026-03-20 13.70
2026-03-19 13.69
2026-03-18 13.69
2026-03-17 13.88
2026-03-16 13.63
2026-03-13 13.69
2026-03-12 13.66
2026-03-11 13.86
2026-03-10 13.70
2026-03-09 14.06
2026-03-06 13.79
2026-03-05 13.70
2026-03-04 13.84
2026-03-03 13.52
2026-03-02 13.62
2026-02-27 14.62
2026-02-26 14.70
2026-02-25 14.85
2026-02-24 14.98
2026-02-23 14.61
2026-02-20 14.48
2026-02-19 14.66
2026-02-18 14.76
2026-02-17 14.63
2026-02-13 14.58
2026-02-12 14.17
2026-02-11 14.25
2026-02-10 14.26
2026-02-09 14.59
2026-02-06 14.57
2026-02-05 14.06
2026-02-04 14.15
2026-02-03 14.13
2026-02-02 14.21
2026-01-30 13.73
2026-01-29 14.03
2026-01-28 14.16
2026-01-27 14.52
2026-01-26 14.47
2026-01-23 14.69
2026-01-22 14.77
2026-01-21 14.87
2026-01-20 14.53
2026-01-16 14.59